Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Future Oncology (London, England)
|
July 16, 2019
Olaparib in germline-mutated metastatic breast cancer: implications of the OlympiAD trial
Anne C Armstrong, Vanessa Clay
Expert Opinion on Pharmacotherapy
|
February 21, 2007
Management of cancer from an unknown primary
Anne C Armstrong, Fiona H Blackhall
Breast Cancer Research : BCR
|
May 31, 2012
Targeting breast cancer vaccines to dendritic cells: improved immunological responses with less protein?
Anne C Armstrong, David E Gilham
Breast Cancer Research and Treatment
|
August 16, 2023
CDK4/6 inhibitors versus weekly paclitaxel for treatment of ER+/HER2- advanced breast cancer with impending or established visceral crisis
Roya Behrouzi, Anne C Armstrong, Sacha J Howell
Expert Review of Vaccines
|
August 7, 2003
Cellular vaccine therapy for cancer
Anne C Armstrong, David Eaton, Joanne C Ewing
Breast Cancer (Dove Medical Press)
|
March 21, 2014
Emerging targeted combinations in the management of breast cancer
Rebecca J Lee, Anne C Armstrong, Andrew M Wardley
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
October 7, 2005
Toward personalized immunotherapy for non-Hodgkin lymphoma: targeting the idiotypic immunoglobulin
Anne C Armstrong, Eleanor J Cheadle, Robert E Hawkins
Women'S Health (London, England)
|
November 28, 2012
Letrozole: advancing hormone therapy in breast cancer
Rebecca J Lee, Anne C Armstrong, Andrew M Wardley
ANZ Journal of Surgery
|
September 30, 2025
Pregnancy Associated Breast Cancer: An Australian Perspective
Caroline MacCallum, Maryam Badawy, Anne C Armstrong, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
April 13, 2004
Adoptive transfer of anti-idiotypic T cells cure mice of disseminated B cell lymphoma
Anne C Armstrong, Said Dermime, Kate Mulryan, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Future Oncology (London, England)
|
July 16, 2019
Olaparib in germline-mutated metastatic breast cancer: implications of the OlympiAD trial
Anne C Armstrong, Vanessa Clay
Expert Opinion on Pharmacotherapy
|
February 21, 2007
Management of cancer from an unknown primary
Anne C Armstrong, Fiona H Blackhall
Breast Cancer Research : BCR
|
May 31, 2012
Targeting breast cancer vaccines to dendritic cells: improved immunological responses with less protein?
Anne C Armstrong, David E Gilham
Breast Cancer Research and Treatment
|
August 16, 2023
CDK4/6 inhibitors versus weekly paclitaxel for treatment of ER+/HER2- advanced breast cancer with impending or established visceral crisis
Roya Behrouzi, Anne C Armstrong, Sacha J Howell
Expert Review of Vaccines
|
August 7, 2003
Cellular vaccine therapy for cancer
Anne C Armstrong, David Eaton, Joanne C Ewing
Breast Cancer (Dove Medical Press)
|
March 21, 2014
Emerging targeted combinations in the management of breast cancer
Rebecca J Lee, Anne C Armstrong, Andrew M Wardley
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
October 7, 2005
Toward personalized immunotherapy for non-Hodgkin lymphoma: targeting the idiotypic immunoglobulin
Anne C Armstrong, Eleanor J Cheadle, Robert E Hawkins
Women'S Health (London, England)
|
November 28, 2012
Letrozole: advancing hormone therapy in breast cancer
Rebecca J Lee, Anne C Armstrong, Andrew M Wardley
ANZ Journal of Surgery
|
September 30, 2025
Pregnancy Associated Breast Cancer: An Australian Perspective
Caroline MacCallum, Maryam Badawy, Anne C Armstrong, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
April 13, 2004
Adoptive transfer of anti-idiotypic T cells cure mice of disseminated B cell lymphoma
Anne C Armstrong, Said Dermime, Kate Mulryan, et al.
Page
of 3